Ronald Cooper's most recent trade in C4 Therapeutics Inc was a trade of 35,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Ronald Harold Wilfred Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 35,500 | 35,500 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| CSG Systems International ... | Ronald H. Cooper | Director | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 25 Feb 2025 | 9,000 | 41,561 (0%) | 0% | 66.6 | 599,580 | Common Stock |
| CSG Systems International ... | Ronald H. Cooper | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2025 | 1,000 | 40,561 (0%) | 0% | 0 | Common Stock | |
| enGene Holdings Inc | Ronald Harold Wilfred Cooper | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 850,000 | 850,000 | - | - | Stock Option (Right to Buy) | |
| enGene Holdings Inc | Ronald H.W. Cooper | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.70 per share. | 27 Sep 2024 | 10,000 | 10,000 | - | 5.7 | 57,000 | Common Shares |
| enGene Holdings Inc | Ronald H.W. Cooper | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2024 | 1,250,000 | 1,250,000 | - | - | Stock Option (Right to Buy) | |
| CSG Systems International ... | Ronald H. Cooper | Director | 10 Jun 2024 | 4,723 | 50,561 (0%) | 0% | 0 | Common Stock | ||
| C4 Therapeutics Inc | Ronald H.W. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Ronald H.W. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| CSG Systems International ... | Ronald H. Cooper | Director | 10 Jun 2023 | 4,060 | 45,838 (0%) | 0% | 0 | Common Stock | ||
| Generation Bio Co | Ronald H.W. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Ronald H.W. Cooper | Director | Grant, award, or other acquisition of securities at price $ 5.12 per share. | 05 Jan 2023 | 9,500 | 9,500 | - | 5.1 | 48,640 | Common Stock |
| CSG Systems International ... | Ronald H. Cooper | Director | 10 Jun 2022 | 2,924 | 41,778 (0%) | 0% | 0 | Common Stock | ||
| Generation Bio Co | Ronald H.W. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,200 | 19,200 | - | - | Stock Option (right to buy) | |
| CSG Systems International ... | Ronald H. Cooper | Director | 10 Sep 2021 | 3,672 | 38,854 (0%) | 0% | 0 | Common Stock | ||
| Generation Bio Co | Ronald H.W. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| CSG Systems International ... | Ronald H. Cooper | Director | 10 Sep 2020 | 4,096 | 35,182 (0%) | 0% | 0 | Common Stock |